MapKure, BeiGene, and SpringWorks launch Phase I cancer study
The trial will enrol adults with a variety of solid tumours. Credit: Penn State.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
